<![CDATA[Pharma — Maj 2022]]>Teva nedjusterer salgsforventningerne https://proinvestor.com/investornyt/817685/teva-nedjusterer-salgsforventningerne

]]>https://dev.proinvestor.com/forum/topic/400862/pharma-maj-2022RSS for NodeSun, 07 Jun 2026 07:07:50 GMTTue, 03 May 2022 09:51:50 GMT60<![CDATA[Reply to Pharma — Maj 2022 on Fri, 27 May 2022 16:42:37 GMT]]>Test

]]>https://dev.proinvestor.com/forum/post/8037606https://dev.proinvestor.com/forum/post/8037606Fri, 27 May 2022 16:42:37 GMT<![CDATA[Reply to Pharma — Maj 2022 on Fri, 20 May 2022 10:39:55 GMT]]>Q&A med CEO Adam Steensberg fra Zealand Pharma starter kl. 15.

]]>https://dev.proinvestor.com/forum/post/8037605https://dev.proinvestor.com/forum/post/8037605Fri, 20 May 2022 10:39:55 GMT<![CDATA[Reply to Pharma — Maj 2022 on Wed, 11 May 2022 05:12:02 GMT]]>Lundbeck/Sydbank: Stærkt regnskab bør give positiv aktiereaktion - NY https://proinvestor.com/investornyt/822639/lundbeck-sydbank-staerkt-regnskab-bor-give-positiv-aktiereaktion-ny

]]>https://dev.proinvestor.com/forum/post/8037604https://dev.proinvestor.com/forum/post/8037604Wed, 11 May 2022 05:12:02 GMT<![CDATA[Reply to Pharma — Maj 2022 on Wed, 11 May 2022 03:54:56 GMT]]>Lundbeck Q1: Nøgleprodukter overrasker positivt https://proinvestor.com/investornyt/822611/lundbeck-q1-nogleprodukter-overrasker-positivt

]]>https://dev.proinvestor.com/forum/post/8037607https://dev.proinvestor.com/forum/post/8037607Wed, 11 May 2022 03:54:56 GMT